CURE PDS
The Product Disclosure Statement (PDS) explains the fees, tax status and some of the risks.
Global X S&P Biotech ETF (ASX:CURE)
The Global X CURE ETF provides investors with exposure to the US biotechnology sub-industry within the health care sector. CURE adopts an equally weighted strategy, which allocates greater exposure to small and mid-cap shares compared to a market capitalisation weighted approach.
CURE ETF review
CURE share price and fees
CURE fees
ASX ticker code: CURE
Yearly fee (MER): 0.45%
FUM: $45.83 million
Monthly spread: 0.25%
Data Last Updated: July 2022
Analyst report
This ETF does not (yet) have an analyst report or rating available. If you would like to request our analyst team cover this ETF, please get in contact with us.
Fee comparison
CURE yearly fee (MER)
0
%
Sector average fee (MER)
0
%
What does the CURE ASX ETF invest in?
The CURE ETF invests in biotechnology stocks trading on major US exchanges. CURE tracks the performance of the S&P Biotechnology Select Industry Index by holding all of the shares that make up the index, closely in proportion to their index weights. These companies are classified as belonging to the GICS biotechnology sub-industry, and must meet certain market capitalisation and liquidity requirements.
What do investors use the CURE ETF for?
CURE could be used by investors to get tactical exposure to a basket of companies within the USA’s biotechnology industry. Most biotech companies are heavily research-focused and their success can often depend on one breakthrough or regulatory approval, making it a speculative industry.
How to buy the CURE ETF
A portfolio FULL of our best ETF ideas
To invest in any ASX ETF, you need to use create your own account or work with a professional who does it for you. But why both? Professional investing done for you, at a really low cost? That’s exactly what we’ve built at Rask Invest.
Click the button to discover how you can create one account and get an automated professionally managed ETF portfolio.
Click the button to discover how you can create one account and get an automated professionally managed ETF portfolio.
CURE investor starter pack
CURE literature
We’ve asked the ETF provider to share their best whitepapers & research with you.
CURE holdings
The Best ETFs team occasionally upload the ETF’s latest investments, so you see what’s inside the ETF.
ASX: CURE’s dividend 2021
When does CURE pay a dividend?
CURE dividend reinvestment plan (DRP)
Warnings we apply to the CURE ETF
CURE tax domicile
CURE ETF registry
Fund issuer
International shares sector data
Sector average return (1Y)
0
%
Average FUM ($m)
$
0
Average fee (MER)
0
%
How CURE compares:
1Y return
0
%
FUM ($m)
$
0
Fee (MER)
0
%
Sector information is recorded based on the last 12-month returns to July 2022. Refer to the Issuer’s website, speak to your financial adviser and always the fund’s Product Disclosure Statement (PDS) before choosing an ETF for its dividend yield, past returns or fees. Past performance can be a poor indicator of future performance.
Latest ETF News
Latest ETF news:
*The warnings on this page are applied by our ETF research team. Please know that these warnings are based on quantitative metrics and our internal methodology. These risks are not exhaustive and therefore they should not be relied upon. Always read the PDS of the function and speak to your financial adviser before acting on this information.
The Best ETF in Australia?
We’ve found the ONE ETF that could rule them all…
Right now, there are 200+ ETFs on the ASX. Then there are index funds. Hundreds of managed funds. LICs. REITs. And everything in between. Wouldn’t it be nice to make ONE investment and build the strong Core of your portfolio — with just one click?
Rask’s lead ETF research analyst and investing team have identified our #1 ETF for 2021 and beyond. Our analyst team has put together a full research report and a step-by-step investment guide to buying this ETF.
Best of all: The report is totally free and will be sent via email.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian-owned.
